For: | Passos DF, Schetinger MRC, Leal DB. Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy. World J Virology 2015; 4(3): 285-294 [PMID: 26279989 DOI: 10.5501/wjv.v4.i3.285] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v4/i3/285.htm |
Number | Citing Articles |
1 |
Filomena Marafon, Cadieli Oliana Reichert, Celso Spada, Margarete Dulce Bagatini. Sinalização purinérgica: implicações fisiopatológicas. 2021; : 306 doi: 10.7476/9786586545494.0017
|
2 |
Davide Ferrari, Michele Rubini, Jorge S. Burns. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.904419
|
3 |
Sobia Manzoor, Umair Akhtar, Sidrah Naseem, Madiha Khalid, Misha Mazhar, Fahed Parvaiz, Saba Khaliq. Ionotropic Purinergic Receptors P2X4 and P2X7: Proviral or Antiviral? An Insight into P2X Receptor Signaling and Hepatitis C Virus Infection. Viral Immunology 2016; 29(7): 401 doi: 10.1089/vim.2016.0008
|
4 |
Sergey V. Stovbun, Tatiana S. Kalinina, Dmitry V. Zlenko, Aleksei V. Kiselev, Alexander A. Litvin, Alexander A. Bukhvostov, Sergey V. Usachev, Dmitry A. Kuznetsov. Antiviral potential of plant polysaccharide nanoparticles actuating non-specific immunity. International Journal of Biological Macromolecules 2021; 182: 743 doi: 10.1016/j.ijbiomac.2021.03.135
|
5 |
Gilnei Bruno da Silva, Geórgia de Carvalho Braga, Júlia Leão Batista Simões, Aniela Pinto Kempka, Margarete Dulce Bagatini. Cytokine storm in human monkeypox: A possible involvement of purinergic signaling. Cytokine 2024; 177: 156560 doi: 10.1016/j.cyto.2024.156560
|
6 |
Zahra Shafaghat, Amir-Hossein Khosrozadeh Ghomi, Hossein Khorramdelazad, Elaheh Safari. Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies. Inflammopharmacology 2023; 31(6): 3005 doi: 10.1007/s10787-023-01344-4
|
7 |
Justyna Suwara, Ewa Radzikowska-Cieciura, Arkadiusz Chworos, Roza Pawlowska. The ATP-dependent Pathways and Human Diseases. Current Medicinal Chemistry 2023; 30(11): 1232 doi: 10.2174/0929867329666220322104552
|